The Food and Drug Administration has removed their black box warning label from hormone-based drugs used to treat menopause symptoms. The warning has appeared on hormone therapy treatments for nearly two decades after a landmark study found the therapy could increase risks of cancer. But now, the FDA is changing course.

Diane Feller is a certified nurse midwife and menopause practitioner at HealthPartners. She joined MPR News host Nina Moini to explain how this decision will impact patients in Minnesota.